| Drug and Dosage | Use | Action | Assessment: Side Effects |
|---|---|---|---|
| Albumin 5%, 25%—IV 500 mL as needed | Cirrhosis Nephrotic syndrome | Provides colloidal oncotic pressure, which mobilizes fluid from extracellular back into intravascular space | Hypersensitivity, CHF, hepatic failure |
| NURSING IMPLICATIONS: Monitor progress of disease; monitor for signs of shock; if fever, tachycardia, or hypotension occur, stop treatment and call physician | |||
* To minimize resistant strains, combination therapy is used long-term.